Perion Announces Participation in Leading Investor Conferences in August and September 2025
Tal Jacobson, CEO, and Elad Tzubey, CFO, will host one-on-one meetings with investors. To request a meeting, please contact your representatives at Canaccord Genuity, Oppenheimer, or Lake Street Capital Markets.
About Perion Network Ltd.
Perion is helping agencies, brands and retailers get better results with their marketing investments by providing advanced technology across digital channels. Through the Perion One platform, we are making digital advertising more effective by building solutions that continuously adapt to connect the dots between data, creative and channels. For more information, visit Perion's website at www.perion.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
a few seconds ago
- Globe and Mail
RCKT Deadline: Rosen Law Firm Urges Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action lawsuit on behalf of purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between September 17, 2024 and May 26, 2025. Rocket Pharmaceuticals is a fully integrated, late-stage biotechnology company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) Misled Investors Regarding its Business Operations. According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) RP-A501 was less effective than defendants had led investors to believe; (2) to increase its effectiveness, Rocket Pharmaceuticals amended RP-A501's clinical trial protocol by introducing a novel immunomodulatory agent; (3) the foregoing increased the risk that patients would suffer from a Serious Adverse Event ('SAE'); (4) accordingly, RP-A501's safety, as well as its clinical, regulatory, and commercial prospects, were overstated; and (5) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. What Now: You may be eligible to participate in the class action against Rocket Pharmaceuticals, Inc. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by August 11, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Rosen Law Firm: Some law firms issuing releases about this matter do not actually litigate securities class actions. Rosen Law Firm does. Rosen Law Firm is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses, improving corporate governance structures, and holding company executives accountable for their wrongdoing. Since its inception, Rosen Law Firm has obtained over $1 billion for shareholders.
Globe and Mail
a few seconds ago
- Globe and Mail
Opendoor Regains Nasdaq Compliance, Cancels Stockholder Meeting
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Opendoor Technologies ( (OPEN)) just unveiled an update. On July 31, 2025, Opendoor Technologies Inc. announced it regained compliance with Nasdaq's minimum bid price requirement, as its stock maintained a closing bid price of at least $1.00 for 12 consecutive business days. Consequently, the company canceled a Special Meeting of Stockholders scheduled for August 27, 2025, which was intended to discuss a reverse stock split, as the Board deemed it unnecessary following the regained compliance. The most recent analyst rating on (OPEN) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Opendoor Technologies stock, see the OPEN Stock Forecast page. Spark's Take on OPEN Stock According to Spark, TipRanks' AI Analyst, OPEN is a Neutral. Opendoor Technologies faces significant financial challenges with declining revenues and negative earnings, leading to a low valuation score. However, technical analysis shows some positive momentum, and the company's strategic initiatives highlighted in the earnings call provide a cautiously optimistic outlook. The overall score reflects these mixed factors, with financial performance being the most significant constraint. To see Spark's full report on OPEN stock, click here. Opendoor Technologies Inc. is a leading e-commerce platform focused on residential real estate transactions, providing a simplified and certain way for people across the U.S. to sell and buy homes. The company operates nationwide and aims to innovate the future of real estate. Average Trading Volume: 175,164,562 Technical Sentiment Signal: Hold Current Market Cap: $1.34B For an in-depth examination of OPEN stock, go to TipRanks' Overview page.
CBC
a minute ago
- CBC
Celtics minority owner reaches deal to buy Connecticut Sun for record $325M US, move team to Boston: reports
A group led by Celtics minority owner Steve Pagliuca has reached a deal to buy the Connecticut Sun for a record $325 million US and move the team to Boston, according to a person familiar with the sale. The franchise wouldn't play in Boston until the 2027 season. Pagliuca also would contribute $100 million for a new practice facility in Boston for the team, the person said. The person spoke to The Associated Press on condition of anonymity on Saturday because the deal hasn't been publicly announced. The sale is pending approval of the league and its Board of Governors. "Relocation decisions are made by the WNBA Board of Governors and not by individual teams," the league said in a statement. The Sun have played one regular season game at TD Garden each of the last two years, including one against Caitlin Clark and the Indiana Fever in July. The league has announced five expansion teams that will begin play over the next five seasons with Portland (2026), Toronto (2026), Cleveland (2028), Detroit (2029) and Philadelphia (2030) joining the WNBA. Each paid a then-record $250 million expansion fee. Nine other cities bid for expansion teams, including Houston, which the league singled out as getting a team in the future when it announced Cleveland, Detroit and Philadelphia in June. Boston did not. "No groups from Boston applied for a team at that time and those other cities remain under consideration based on the extensive work they did as part of the expansion process and currently have priority over Boston. Celtics' prospective ownership team has also reached out to the league office and asked that Boston receive strong consideration for a WNBA franchise at the appropriate time." The Boston Globe first reported the sale. The Sun are owned by the Mohegan Tribe, which runs the casino where the team has played since 2003. The Tribe bought the franchise for $10 million and relocated it from Orlando that year. The Connecticut franchise was the first in the league to be run by a non-NBA owner and also became the first to turn a profit. The team announced in May that it was searching for a potential buyer for the franchise and had hired investment bank Allen & Company to conduct the probe. The WNBA has experienced rapid growth the last few seasons and ownership groups have been investing more into their teams, including player experiences. That has come in the way of practice facilities. The Sun are one of the few teams in the league that haven't announced any plans for a new training facility. Connecticut practices either at the arena in the casino or a local community centre. Despite the lack of facilities, the Sun have been one of the most successful teams in the league, making the post-season in 16 seasons, including a run of six straight semifinal appearances. But the team was hit hard this off-season with the entire starting five from last season leaving either via free agency or trade. Connecticut is currently in last place in the WNBA at 5-21. The team sent out a letter to season ticket holders last week saying they'd still be playing at the casino next year. The last team to be sold in the WNBA was in 2021 when real estate investor Larry Gottesdiener led a group that bought the Atlanta Dream for under $10 million. A year earlier, Mark Davis paid roughly $2 million for the Las Vegas Aces.
